Valuation Oscotec Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-26			5-day change	1st Jan Change
36,000.00 ^KRW	-3.36%		-6.01%	-20.35%

08-14	Oscotec Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-01	Agios Pharmaceuticals, Inc. Enters Exclusive Global License Agreement with Oscotec, Inc. to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,110,134	655,533	880,167	936,041	1,729,270	1,377,294	-	-
Change	-	-40.95%	34.27%	6.35%	84.74%	-20.35%	-	-
Enterprise Value (EV) ¹	1,102	655.5	807.3	839.4	1,637	1,192	1,073	920.3
Change	-	-40.54%	23.15%	3.98%	94.99%	-27.16%	-9.98%	-14.26%
P/E	-	-22.7x	-	1,059x	33x	42.8x	11.5x	8.92x
PBR	-	-	8.85x	7.29x	9.54x	6.71x	4.24x	2.87x
PEG	-	-	-	-	0x	-1.1x	0x	0.3x
Capitalization / Revenue	284x	-	178x	27.5x	17.3x	16.4x	7.17x	5.79x
EV / Revenue	282x	-	163x	24.7x	16.4x	14.2x	5.59x	3.87x
EV / EBITDA	-36.5x	-	-26.1x	-932x	30.5x	29.8x	7.61x	5.06x
EV / EBIT	-35x	-	-24.7x	-316x	31.4x	35.1x	7.78x	5.08x
EV / FCF	-	-	-35.7x	-31.6x	217x	11.8x	8.94x	6.01x
FCF Yield	-	-	-2.8%	-3.16%	0.46%	8.47%	11.2%	16.6%
Dividend per Share ³	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ³	-	-763	-	23	1,368	841	3,121	4,037
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3.903	-	4.951	34.01	99.84	84	192	238
EBITDA ¹	-30.18	-	-30.9	-0.9011	53.73	40	141	182
EBIT ¹	-31.5	-	-32.66	-2.654	52.08	34	138	181
Net income ¹	-	-24.43	-	0.8765	54.75	32	119	154
Net Debt ¹	-7.639	-	-72.87	-96.6	-92.47	-185	-304	-457
Reference price ³	36,600.00	17,300.00	23,050.00	24,350.00	45,200.00	36,000.00	36,000.00	36,000.00
Nbr of stocks (in thousands)	30,332	37,892	38,185	38,441	38,258	38,258	-	-
Announcement Date	2/9/22	3/17/23	3/18/24	2/26/25	2/27/26	-	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
OSCOTEC INC.	44.29x	14.76x	31x	-	1.08B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	30.98x	7.81x	19.93x	2.12%	400.47B
Weighted average by Cap.	35.23x	8.30x	20.40x	1.8%